The impact of COVID-19 on the clinical outcome of patients with cirrhosis deserves more attention and research.

Gao, Feng; Huang, Zhi-Ming

Gao, Feng; Huang, Zhi-Ming.

Gao F; Department of Gastroenterology and Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Electronic address: gaofeng@wmu.edu.cn.
Huang ZM; Department of Gastroenterology and Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Electronic address: wyyhzm@126.com.

J Hepatol ; 73(6): 1568-1569, 2020 12.

Article in English | MEDLINE | ID: covidwho-609162

Subject(s)

COVID-19; Humans; Liver Cirrhosis/complications; Liver Cirrhosis/epidemiology; Liver Cirrhosis/therapy; Pandemics; Research; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: J Hepatol Journal subject: Gastroenterology Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google